![semaglutide phase 2 In this trial in participants with obesity, treatment with bimagrumab plus for 72 weeks resulted in substantial reductions in body weight. The safety findings were consistent with the known PDF] A Phase 2, Randomized,](https://pbs.twimg.com/media/HDh4lYPbAAEoT-_.jpg)
semaglutide phase 2
Shipping Estimate
semaglutide phase 2 In this trial in participants with obesity, treatment with bimagrumab plus for 72 weeks resulted in substantial reductions in body weight. The safety findings were consistent with the known PDF] A Phase 2, Randomized,
EUR28.19
EUR67.19
Pay in 4 interest-free payments of $7.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
![semaglutide phase 2 In this trial in participants with obesity, treatment with bimagrumab plus for 72 weeks resulted in substantial reductions in body weight. The safety findings were consistent with the known PDF] A Phase 2, Randomized,](https://ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/7c7543416a247a5a34e98769da2d20a023a4651c/6-Figure2-1.png)
![semaglutide phase 2 In this trial in participants with obesity, treatment with bimagrumab plus for 72 weeks resulted in substantial reductions in body weight. The safety findings were consistent with the known PDF] A Phase 2, Randomized,](https://www.thelancet.com/cms/10.1016/S2213-8587(26)00125-7/asset/85fa7e17-4785-4f71-9b61-806d7ecb7b4a/main.assets/gr2_lrg.jpg)
![semaglutide phase 2 In this trial in participants with obesity, treatment with bimagrumab plus for 72 weeks resulted in substantial reductions in body weight. The safety findings were consistent with the known PDF] A Phase 2, Randomized,](https://acceptingtherapy.com/wp-content/uploads/2024/05/1.png)
![semaglutide phase 2 In this trial in participants with obesity, treatment with bimagrumab plus for 72 weeks resulted in substantial reductions in body weight. The safety findings were consistent with the known PDF] A Phase 2, Randomized,](https://substackcdn.com/image/fetch/$s_!WuaA!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F706b1a6e-5358-44b7-80cf-1b7d1a43735b_2868x1320.png)
![semaglutide phase 2 In this trial in participants with obesity, treatment with bimagrumab plus for 72 weeks resulted in substantial reductions in body weight. The safety findings were consistent with the known PDF] A Phase 2, Randomized,](https://www.lambda-cro.com/wp-content/uploads/2025/11/Semaglutide.jpg)
